Evidence map›Paper›PMID 27718252›Full record

SynthesisBritish journal of clinical pharmacology2017

Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review.

Zohaib Akram, Tariq Abduljabbar, Sergio Varela Kellesarian, Mohamed Ibrahim Abu Hassan, Fawad Javed, Fahim Vohra

Open access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in British journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Article
  12. Roles of osteoclasts in alveolar bone remodeling.Genesis (New York, N.Y. : 2000) · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Bisphosphonate-based surface biofunctionalization improves titanium biocompatibility.Journal of materials science. Materials in medicine · 2020
    Article
  19. The Role of Matrix Metalloproteinases in Periodontal Disease.International journal of environmental research and public health · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Zohaib AkramDepartment of Periodontology, Faculty of Dentistry, Ziauddin University, Karachi, 75600, Pakistan.
Tariq AbduljabbarDepartment of Prosthetic Dental Sciences, College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
Sergio Varela KellesarianDepartment of General Dentistry, Eastman Institute for Oral Health, University of Rochester, New York, 14620, USA.
Mohamed Ibrahim Abu HassanDean, Faculty of Dentistry, University Technology MARA, Shah Alam, Malaysia.
Fawad JavedDepartment of General Dentistry, Eastman Institute for Oral Health, University of Rochester, New York, 14620, USA.
Fahim VohraDepartment of Prosthetic Dental Sciences, College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
King Saud University · SAEastman Chemical Company (United States) · USUniversiti Teknologi MARA System · MYUniversity of Rochester · USZiauddin University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aim of this systematic review was to assess the efficacy of bisphosphonate therapy as an adjunct to scaling and root planing (SRP) in the management of periodontitis.

methodsDatabases (MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and Cochrane Oral Health Group Trials Register databases) were searched up to and including July 2016. The primary outcome was probing depth (PD), and the secondary outcomes were changes in clinical attachment level (CAL) and bone defect (BD) fill. The mean differences (MD) of outcomes and 95% confidence intervals (CI) for each variable were calculated using random effect model.

resultsEight clinical studies were included. Seven studies used alendronate as an adjunct to SRP; of these, four studies used topical application and three used oral alendronate. Considering the effects of adjunctive bisphosphonates as compared to SRP alone, a high degree of heterogeneity for PD (Q value = 39.6, P < 0.0001, I

conclusionsAdjunctive bisphosphonate therapy appears to be effective in managing periodontitis, however, due to the potential risk of osteonecrosis of the jaws and short-term follow-up of the studies, their clinical application is debatable.

Indexed as

Administration, OralAdministration, TopicalAlendronateChronic PeriodontitisCombined Modality TherapyDental ScalingDiphosphonatesHumansRoot PlaningAlendronateDiphosphonatesBisphosphonatesperiodontal diseasescaling and root planningsystematic review

Identifiers

PMID27718252
PMCPMC5306480
OpenAlexW2529806247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.